Clinical features and X-inactivation in females heterozygous for creatine transporter defect
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The creatine transporter defect is an X-linked cause of mental retardation. We investigated the clinical features and pattern of X-inactivation in a Dutch cohort of eight female heterozygotes. We show that symptoms of the creatine transporter defect (mental retardation, learning difficulties, and constipation) can be present in female heterozygotes. We further show that the diagnosis in females is not straightforward: (i) The creatine/creatinine ratio in urine was elevated only in three of eight females. (ii) Although as a group the females had a significantly decreased cerebral creatine concentration, individual females had creatine concentrations overlapping with normal controls. (iii) Skewed X-inactivation was found in the cultured fibroblasts, in favour of either the mutated or the wild-type allele, leading to either deficient or normal results in the creatine uptake studies in fibroblasts. Thus, screening by these tests is unreliable for the diagnosis. In addition, we found no consistent skewing of the X-inactivation in peripheral tissues indicating that there is no selection against the creatine transporter defect. We conclude that testing for creatine transporter defect should be considered in females with (mild) mental retardation. Screening by DNA analysis of the SLC6A8 gene is recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massive IQ gains in 14 nations: What IQ tests really measure.
Flynn, J. R. (1987) · Psychological Bulletin · doi:10.1037/0033-2909.101.2.171 · Cited by 1,918 · cited 1×
“Because of the Flynn effect (mean performance on IQ tests increases from one generation to the next) (33), the norms for the GIT-IQ test have recently been updated (GIT-2) and higher IQ scores would have been found if the original GIT or other older IQ test would have been used.”
Method
Cited by
Phenotype and genotype in 101 males with X-linked creatine transporter deficiency
van de Kamp, J. M., Betsalel, O. T., Mercimek-Mahmutoglu, S., Abulhoul, L., Grünewald, S., Anselm, I., Azzouz, H., Bratkovic, D., de Brouwer, A., Hamel, B., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101658 · Cited by 164
Self-citationCreatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112
“…with arginine and glycine as precursors of Cr gave somemodest encouraging results in two SLC6A8-deficient patients (Chilosi et al. 2008; Wilcken et al. 2008), while it failed to improve the neurological status of many others (Fons et al. 2008; Valayannopoulos et al. 2011; van de Kamp et al. 2011b).”
BackgroundResultHanna-El-Daher, L., & Braissant, O. (2016) · Amino Acids · doi:10.1007/s00726-016-2189-0 · Cited by 65
Brand, B. A., Blesson, A. E., & Smith-Hicks, C. L. (2021) · Brain Sciences · doi:10.3390/brainsci11070904 · Cited by 39
Metadata
- Authors
- van de Kamp, J., Mancini, G., Pouwels, P., Betsalel, O., van Dooren, S., de Koning, I., Steenweg, M., Jakobs, C., van der Knaap, M., & Salomons, G.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2011-02-07
- Volume
- 79
- Issue
- 3
- Pages
- 264-272
- ISSN
- 0009-9163 (ISSN-L)
- OpenAlex
- W2161604667
- Cited by
- 88
- References
- 1
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical features and X-inactivation in females heterozygous for creatine transporter defect. https://app.cochat.ai/papers/10.1111/j.1399-0004.2010.01460.x
- The paper
- van de Kamp, J., Mancini, G., Pouwels, P., Betsalel, O., van Dooren, S., de Koning, I., Steenweg, M., Jakobs, C., van der Knaap, M., & Salomons, G. (2011). Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clinical Genetics. https://doi.org/10.1111/j.1399-0004.2010.01460.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.